Intellia Therapeutics, Inc.
Intellia Therapeutics, Inc. (NTLA) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · NTLA · as of Jun 9, 2026
Key Statistics
Explore Intellia Therapeutics, Inc. Data
ntla stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 39 · Buy rate: 71.8%
The NTLA analyst consensus is Buy, based on ratings from 39 Wall Street analysts over the past 3 months. The average 12-month price target is $26.29, representing +94.89% upside from the current price of $13.49.
Competitors & Peers
ntla competitorsNTLA
BCRX
BHVN
IMNM
PHVS
STOKStock Performance
Full HistoryAbout Intellia Therapeutics, Inc.
Intellia Therapeutics, Inc. is a biotechnology firm dedicated to advancing therapeutic treatments through its expertise in genome editing. The company's pipeline includes several in vivo (administered…
what is intellia therapeutics, inc. · ntla stock overview · intellia therapeutics, inc. company profile · who is intellia therapeutics, inc. ceo · ntla NASDAQ · intellia therapeutics, inc. headquarters · intellia therapeutics, inc. business segments
About Stock Overview & Key Data
Intellia Therapeutics, Inc. (NTLA) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since May 6, 2016. As of the latest trading session, NTLA stock price is $13.49, with a market capitalization of $1.5B. The stock has returned +62.80% over the past 12 months and +49.94% year-to-date.
According to 39 Wall Street analysts, the consensus rating for Intellia Therapeutics, Inc. stock is Buy, with an average 12-month price target of $26.29. In fiscal year 2025, Intellia Therapeutics, Inc. reported revenue of $67.7M and net income of -$412.7M. For detailed data — including Intellia Therapeutics, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Intellia Therapeutics, Inc. (NTLA) stock price is $13.49. The stock is traded on NASDAQ under the ticker symbol NTLA. The 52-week range is $7.95 – $28.25.